探索澳大利亚地区,农村和偏远地区的帕金森病患病率:系统范围审查
Shanna Fealy1,2,3, Patricia A Logan4,5, Peter S Micalos4,5
1Ageing Well in Rural and Regional Australia Research Group, Charles Sturt University, Port Macquarie, New South Wales, Australia.
The Australian journal of rural health
|October 28, 2023
概括
澳大利亚的帕金森病 (PD) 患病率差异很大,农村地区的数据有限. 需要更多的研究来确保所有患有PD的澳大利亚人得到公平的护理.
科学领域:
- 神经科学是一个神经科学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 是一个重要的全球性神经退行性疾病.
- 人口日益老龄化预计会增加PD患病率,特别是在澳大利亚等西方国家.
研究的目的:
- 调查帕金森病 (PD) 在澳大利亚区域,农村和偏远地区的流行情况.
- 在澳大利亚不同地区提供PD专用医疗保健服务的公平提供.
主要方法:
- 根据乔安娜·布里格斯研究所和PRISMA-ScR指南进行了全面的范围审查.
- 进行了广泛的电子数据库搜索和谷歌学者,严格的文章选和质量评估由多个审稿人进行.
主要成果:
- 包括了1966年至2019年间发表的6项研究,揭示了PD患病率的显著变化 (每1000人0.58至8.5).
- 初步发现表明,与城市中心相比,澳大利亚区域,农村和偏远地区的PD患病率可能更高.
结论:
- 数据的稀缺性和广泛的流行率变化阻碍了对医疗保健规划和资源分配的最终结论.
- 迫切需要进行强有力的,国家特定的流行病学研究,以准确评估PD的影响并指导公共卫生战略,特别是在服务不足的农村和偏远地区.
相关概念视频
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Prevalence and Incidence
585
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
585
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


